The interaction between gut microbiota and age-related changes in immune function and inflammation

Immunity & Ageing

Emilio Jirillo¹  Thea Magrone¹ 

[1] Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, Policlinico, Piazza G. Cesare 11, 70124, Bari, Italy

关键词: Microbiota;    Immunity;    Gut;    Ageing;   

Others  :  814907
DOI  :  10.1186/1742-4933-10-31

 received in 2012-11-23, accepted in 2013-05-10,  发布年份 2013

【 摘 要 】

Intestinal microbiota and gut immune systems interact each other, maintaining a condition of homeostasis in the context of the intestinal habitat. However, both systems undergo modifications in elderly, thus accounting for a low grade inflammatory status which, in turn, may evolve toward more severe pathological conditions such as inflammatory bowel disease and colon rectal cancer. In addition, in western societies dietary habits may negatively influence the microbiota composition, also altering gut immune response which is per se impaired in elderly. In order to prevent the outcome of aged-related disease, supplementation of nutraceuticals able to correct abnormalities of both immune system and microbiota has become more frequent than in the past. In this respect, a better identification of components of the aged microbiota as well as a deeper analysis of gut mucosal immunity function should be pursued.

【 授权许可】

   
2013 Magrone and Jirillo; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Moore WE, Holdeman LV: Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974, 27:961-979.
• [2]Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
• [3]Ouwehand A, Vesterlund S: Health aspects of probiotics. IDrugs 2003, 6:573-580.
• [4]Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM: Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002, 68:3401-3407.
• [5]Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
• [6]Louis P, Scott KP, Duncan SH, Flint HJ: Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007, 102:1197-1208.
• [7]Miron N, Cristea V: Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol 2012, 167:405-412.
• [8]Kraehenbuhl JP, Neutra MR: Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000, 16:301-332.
• [9]Iwasaki A: Mucosal dendritic cells. Annu Rev Immunol 2007, 25:381-418.
• [10]Kanai T, Mikami Y, Sujino T, Hisamatsu T, Hibi T: RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation. Mucosal Immunol 2012, 5:240-247.
• [11]Maldonado RA, von Andrian UH: How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 2010, 108:111-165.
• [12]Hadis U, Wahl B, Schulz O, Hardtke-Wolenski M, Schippers A, Wagner N, Müller W, Sparwasser T, Förster R, Pabst O: Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011, 34:237-246.
• [13]Agace WW, Persson EK: How vitamin A metabolizing dendritic cells are generated in the gut mucosa. Trends Immunol 2012, 33:42-48.
• [14]Dicarlo AL, Fuldner R, Kaminski J, Hodes R: Aging in the context of immunological architecture, function and disease outcomes. Trends Immunol 2009, 30:293-294.
• [15]Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P: Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 2012.
• [16]Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G: Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008, 23:64-74.
• [17]Magrone T, Jirillo E: The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 2013, 9(7):1329-1342.
• [18]Round JL, Mazmanian SK: Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
• [19]Davies JM, Sheil B, Shanahan F: Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation. Immunology 2009, 128(Suppl 1):e805-e815.
• [20]Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR: Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
• [21]Feng T, Wang L, Schoeb TR, Elson CO, Cong Y: Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010, 207:1321-1332.
• [22]Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O'Toole PW: Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4586-4591.
• [23]Hopkins MJ, Sharp R, Macfarlane GT: Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001, 48:198-205.
• [24]He T, Harmsen HJ, Raangs GC, Welling GW: Composition of faecal microbiota of elderly people. Microb Ecol Health Dis 2003, 15:153-159.
• [25]Harmsen HJ, Wildeboer-Veloo AC, Grijpstra J, Knol J, Degener JE, Welling GW: Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000, 66:4523-4527.
• [26]Tiihonen K, Ouwehand AC, Rautonen N: Human intestinal microbiota and healthy ageing. Ageing Res Rev 2010, 9:107-116.
• [27]Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C, Brigidi P, De Vos W: Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010, 5:e10667.
• [28]Pédron T, Sansonetti P: Commensals, bacterial pathogens and intestinal inflammation: an intriguing ménage à trois. Cell Host Microbe 2008, 3:344-347.
• [29]De Vuyst L, Leroy F: Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 2011, 149:73-80.
• [30]Ioannidis O, Varnalidis I, Paraskevas G, Botsios D: Nutritional modulation of the inflammatory bowel response. Digestion 2011, 84:89-101.
• [31]Schiffrin EJ, Morley JE, Donnet-Hughes A, Guigoz Y: The inflammatory status of the elderly: the intestinal contribution. Mutat Res 2010, 690:50-56.
• [32]Manichanh C, Borruel N, Casellas F, Guarner F: The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012, 9:599-608.
• [33]Kraus S, Arber N: Inflammation and colorectal cancer. Curr Opin Pharmacol 2009, 9:405-410.
• [34]Kinross J, Nicholson JK: Gut microbiota: dietary and social modulation of gut microbiota in the elderly. Nat Rev Gastroenterol Hepatol 2012, 9:563-564.
• [35]Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
• [36]Candore G, Caruso C, Jirillo E, Magrone T, Vasto S: Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr Pharm Des 2010, 16:584-596.
• [37]Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A: Prebiotic effects: metabolic and health benefits. Br J Nutr 2010, 104(Suppl 2):S1-S63.
• [38]Hume ME: Historic perspective: prebiotics, probiotics, and other alternatives to antibiotics. Poult Sci 2011, 90:2663-2669.
• [39]Wallace TC, Guarner F, Madsen K, Cabana MD, Gibson G, Hentges E, Sanders ME: Human gut microbiota and its relationship to health and disease. Nutr Rev 2011, 69:392-403.
• [40]de LeBlanc AM, Castillo NA, Perdigon G: Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. Int J Food Microbiol 2010, 138:223-231.
• [41]Macpherson AJ, Slack E: The functional interactions of commensal bacteria with intestinal secretory IgA. Curr Opin Gastroenterol 2007, 23:673-678.
• [42]Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH: Generation of regulatory dendritic cells and CD4 + Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 2010, 107:2159-2164.
• [43]Gill HS, Rutherfurd KJ, Cross ML, Gopal PK: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001, 74:833-839.
• [44]Shinkai S, Toba M, Saito T, Sato I, Tsubouchi M, Taira K, Kakumoto K, Inamatsu T, Yoshida H, Fujiwara Y, Fukaya T, Matsumoto T, Tateda K, Yamaguchi K, Kohda N, Kohno S: Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2012, 1-10. http://dx.doi.org/10.1017/S0007114512003753 webcite
• [45]Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT: Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 2005, 40:28-37.
• [46]Amati L, Marzulli G, Martulli M, Pugliese V, Caruso C, Candore G, Vasto S, Jirillo E: Administration of a synbiotic to free-living elderly and evaluation of serum cytokines. A pilot study. Curr Pharm Des 2010, 16:854-858.
• [47]Vendrame S, Guglielmetti S, Riso P, Arioli S, Klimis-Zacas D, Porrini M: Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut. J Agric Food Chem 2011, 59:12815-12820.
• [48]Jacobs DM, Deltimple N, van Velzen E, van Dorsten FA, Bingham M, Vaughan EE, van Duynhoven J: (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed 2008, 21:615-626.
• [49]Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andrés-Lacueva C, Tinahones FJ: Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 2012, 95:1323-1334.
• [50]Magrone T, Marzulli G, Jirillo E: Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. Curr Pharm Des 2012, 18:34-42.
• [51]Kawaguchi K, Matsumoto T, Kumazawa Y: Effects of antioxidant polyphenols on TNF-alpha-related diseases. Curr Top Med Chem 2011, 11:1767-1779.
• [52]Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M: Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Res Rev 2012, 11:297-319.
• [53]Dhonukshe-Rutten RA, Lips M, de Jong N, Chin A, Paw MJ, Hiddink GJ, van Dusseldorp M, De Groot LC, van Staveren WA: Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr 2003, 133:801-807.
• [54]Sartor RB: Gut microbiota: Diet promotes dysbiosis and colitis in susceptible hosts. Nat Rev Gastroenterol Hepatol 2012, 9:561-562.
• [55]Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB: Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012, 487:104-108.
• [56]Fujihashi K, Kiyono H: Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 2009, 30:334-343.
• [57]Rehman T: Role of the gut microbiota in age-related chronic inflammation. Endocr Metab Immune Disord Drug Targets 2012, 12(4):361-367.